| Literature DB >> 19148310 |
Caroline Lacroix1, Philippe Martin, Sebastien Turcotte, Steven DeRoche, Vanessa Magluilo, Christine Lacroix.
Abstract
INTRODUCTION: Despite being more prevalent in developing countries, tuberculosis (TB) remains an important health problem in Canada. Long diagnosis delays of respiratory tuberculosis are associated with adverse consequences for the patient but also for the community. From a public health perspective, identification of factors associated with long delays of diagnosis could help reduce these delays.Entities:
Keywords: Tuberculosis; consequences of delay; delay of diagnosis; immigration; treatment delay
Year: 2008 PMID: 19148310 PMCID: PMC2582667
Source DB: PubMed Journal: Mcgill J Med ISSN: 1201-026X
Variable Definitions
| Delay of diagnosis | Number of days between the beginning of the disease date and the diagnostic date, inclusively |
| Pre-test delay | Number of days between the beginning of the disease date and the first sputum sampling date, inclusively |
| Test delay | Number of days between the first sputum sampling date and the diagnostic date, inclusively |
| Patient delay | Number of days between the beginning of the disease date and the first consultation date |
| Suspicion delay | Number of days between the first contact with the health care system date and the first sputum sampling date |
| HSSC with a high exposition to tuberculosis | A HSSC in Monteregie with an average of at least 3 cases of tuberculosis each year between 2004 and 2006, according to the statistics from the Public Health Department of Monteregie [ |
| Endemic native country | A country with an estimated incidence of positive smear tuberculosis of at least 30 cases / 100 000 between 2003 and 2005, according to the Global Health Atlas of the WHO [ |
| Number of years since arrival in Canada | Number of years between the diagnosis and the arrival in Canada (for immigrants) |
| Presenting symptoms | Symptoms included in the questionnaire : fever, nocturnal sweats, weigh loss and/or non specific general malaise, cough, expectorations, haemoptysis, thoracic or pleuritic pain |
| Duration of hospitalisation | Number of days between the admission date and the end of hospitalisation, inclusively |
| Number of contacts | Number of persons identified as being close contacts of the index case of tuberculosis during the standardized inquiry by the PHD |
| Proportion of contacts with positive TST | Proportion of index case close contacts that had a TST result of 5 mm or more in one of the two tests |
| Attribuable deaths | Death directly caused by or favoured by tuberculosis |
Delays of diagnosis in relation to the different variables studied.
| Socio-demographic variables | Number (%) | Aver. delay of diagnosis (in days) | CI 95% | p value |
|---|---|---|---|---|
| Sex | 115 | |||
| | 72 (62.6) | 90.8 | 74.5–107.1 | 0.774 |
| | 43 (37.4) | 94.4 | ||
| Age | 115 | |||
| | 8 (7.0) | 71.6 | 24.1–119.2 | 0.752 |
| | 25 (21.7) | 87.8 | 68.9–106.6 | |
| | 35 (30.4) | 93.9 | 72.0–115.7 | |
| | 47 (40.9) | 96.7 | 77.0–116.4 | |
| HSSC | 115 | |||
| | 52 (45.2) | 94.5 | 74.9–114.1 | 0.719 |
| | 63 (54.8) | 90.2 | 76.4–104.0 | |
| Native Country | 114 | |||
| | 62 (54.4) | 105.1 | 87.7–122.5 | |
| | 36 (31.6) | 80.4 | 64.2–96.6 | 0.066c,e |
| | 16 (14.0) | 73.9 | 46.1–101.1 | 0.102c,f |
| # of years since arrival in Canada | 51 | |||
| | 27 (52.9) | 81.7 | 62.9–100.5 | 0.599 |
| | 24 (47.1) | 74.0 | 52.3–95.7 | |
| Presenting Symptoms | ||||
| Fever & or nocturnal sweat | 115 | |||
| | 66 (57.4) | 99.1 | 82.9–115.3 | 0.175 |
| | 49 (42.6) | 82.8 | 66.6–99.0 | |
| Weight loss & or non-specific gen. malaise | 115 | |||
| | 76 (66.1) | 102.4 | 88.2–116.6 | 0.016 |
| | 39 (33.9) | 72.3 | 53.4–91.2 | |
| Cough &/or expectoration | 115 | |||
| | 91 (79.1) | 95.1 | 82.0–108.2 | 0.335 |
| | 24 (20.9) | 81.0 | 56.3–105.7 | |
| Haemoptysis | 97 | |||
| | 20 (20.6) | 109.0 | 78.0–140.0 | 0.122 |
| | 77 (79.4) | 85.1 | 72.1–98.1 | |
| Antecedents | ||||
| Smoking | 61 | |||
| | 19 (31.1) | 88.7 | 64.0–113.4 | 0.599 |
| | 42 (68.9) | 98.9 | 75.9–121.9 | |
| Known contact w TB pxt | 94 | |||
| | 40 (42.6) | 88.8 | 68.4–109.2 | 0.865 |
| | 54 (57.4) | 91.1 | 75.0–107.2 | |
| HIV sero(+)ve & or immunosupp. | 71 | |||
| | 7 (9.9) | 112.3 | 51.4–173.2 | 0.295 |
| | 64 (90.1) | 85.5 | 70.4–100.6 | |
| Stay in an endemic country | 105 | |||
| | 40 (38.1) | 82.9 | 64.9–100.9 | 0.356 |
| | 65 (61.9) | 94.1 | 79.2–109.0 | |
| Paraclinic Tests | ||||
| Chest Xray result | 115 | |||
| | 88 (76.5) | 91.0 | 77.9–104.1 | 0.729 |
| | 27 (23.5) | 95.9 | 70.8–121.0 | |
| Smear | 111 | |||
| | 67 (60.4) | 93.7 | 79.7–107.7 | 0.711 |
| | 44 (39.6) | 89.3 | 69.7–108.9 | |
| PCR | 115 | |||
| | 77 (67.0) | 89.3 | 76.4–102.2 | 0.498 |
| | 38 (33.0) | 97.9 | 74.2–121.6 | |
Proportion expressed in percentage of the total of valid cases for each variable;
For immigrants only;
Student t test;
ANOVA test;
Comparison of the average delays of diagnosis between Canadian born patients and foreign-born patients of endemic countries;
Comparison of the average delays of diagnosis between Canadian born patients and foreign-born patients of non-endemic countries (beside Canada)
The different delays analysed in this study
| Delays | Median delay (days) | Average delay (days) | CI 95% | Range (days) |
|---|---|---|---|---|
| Delay of diagnosis | 83.0 | 92.2 | 80.6–103.8 | (3, 344) |
| Pre-test delay | 61.0 | 76.1 | 64.9–87.3 | (0, 335) |
| Test delay | 7.0 | 15.0 | 11.6–19.4 | (−4, 133) |
The possible consequences studied in relation to delays of diagnosis a Proportion expressed in percentage of the total of valid cases for each variable
| Short Delay | Long Delay | p value | |
|---|---|---|---|
| Contacts | 0.123 | ||
| Number of cases concerned (%)a | 64 (61.5) | 40 (38.5) | |
| Average number of contacts (CI 95%) | 15.1 (7.1–23.2) | 13.7 (10.5–16.8) | |
| Median number of contacts | 7.0 | 13.0 | |
| Positive TST results among close contacts | 0.703 | ||
| Number of cases concerned (%)a | 60 (60.6) | 39 (39.4) | |
| Average proportion of +ve results among close contacts (CI 95%) | 0.419 (0.329–0.509) | 0.393 (0.303–0.483) | |
| Hospitalisation | 0.107 | ||
| # of pxts hospitalised (%)a | 50 (68.5) | 23 (31.5) | |
| # of pxts non hospitalised (%)a | 21 (52.5) | 19 (47.5) | |
| Average duration of hospitalisation (days) (CI 95%) | 25.9 (18.8–33.0) | 26.5 (8.9–44.1) | 0.951 |
| Outcome of the disease | 0.776 | ||
| Healing (%)a | 56 (64.4) | 31 (35.6) | |
| Death (%)a | 9 (0.6) | 6 (0.4) | |